These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19061136)

  • 1. Diethylstilbestrol (DES) labeled with Auger emitters: potential radiopharmaceutical for therapy of estrogen receptor-positive tumors and their metastases?
    Fischer T; Schomacker K; Schicha H
    Int J Radiat Biol; 2008 Dec; 84(12):1112-22. PubMed ID: 19061136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor status and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol.
    Brandes LJ; Hermonat MW
    Cancer Res; 1983 Jun; 43(6):2831-5. PubMed ID: 6850594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose.
    DeSombre ER; Shafii B; Hanson RN; Kuivanen PC; Hughes A
    Cancer Res; 1992 Oct; 52(20):5752-8. PubMed ID: 1394199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetics of receptor-mediated radiotoxicity of 16alpha-[125I]-iodostradiol-3,17beta].
    Schomäcker K; Fischer T; Böttcher B; Mraheel SA; Scharl A; Gabruk-Szostak B; Scheidhauer K; Göhring UJ; Meller-Rehbein B; Shukla SK; Schicha H
    Nuklearmedizin; 1998 Jun; 37(4):134-40. PubMed ID: 9650213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma.
    Nam K; Marshall P; Wolf RM; Cornell W
    Biopolymers; 2003 Jan; 68(1):130-8. PubMed ID: 12579585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
    Boyd M; Sorensen A; McCluskey AG; Mairs RJ
    J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor-mediated cytotoxicity using iodine-125.
    Bloomer WD; McLaughlin WH; Milius RA; Weichselbaum RR; Adelstein SJ
    J Cell Biochem; 1983; 21(1):39-45. PubMed ID: 6874726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression induced by diethylstilbestrol (DES) in human primitive Mullerian duct cells using microarray.
    Miki Y; Suzuki T; Tazawa C; Ishizuka M; Semba S; Gorai I; Sasano H
    Cancer Lett; 2005 Apr; 220(2):197-210. PubMed ID: 15766595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of diethylstilbestrol carcinogenicity as studied with the fluorinated analogue E-3',3",5',5"-tetrafluorodiethylstilbestrol.
    Liehr JG; Ballatore AM; McLachlan JA; Sirbasku DA
    Cancer Res; 1983 Jun; 43(6):2678-82. PubMed ID: 6850586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
    Govindan SV; Goldenberg DM; Elsamra SE; Griffiths GL; Ong GL; Brechbiel MW; Burton J; Sgouros G; Mattes MJ
    J Nucl Med; 2000 Dec; 41(12):2089-97. PubMed ID: 11138697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss and mutations in a new ETRG-1 gene are early events in diethylstilbestrol-induced renal carcinogenesis in Syrian hamsters.
    Singh KP; Roy D
    Gene; 2008 Jan; 408(1-2):18-26. PubMed ID: 18068315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental study on relationship between exogenous estrogen and breast cancer risk.
    Zeng X; Yao Z
    Chin Med J (Engl); 1997 May; 110(5):388-91. PubMed ID: 9594309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steps towards cancer therapy with radionuclides--a review including radiation biophysical aspects.
    Kampf G
    Radiobiol Radiother (Berl); 1990; 31(3):215-29. PubMed ID: 2201055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative biological effectiveness of accumulated 125IdU and 125I-estrogen decays in estrogen receptor-expressing MCF-7 human breast cancer cells.
    Yasui L; Hughes A; DeSombre E
    Radiat Res; 2001 Feb; 155(2):328-34. PubMed ID: 11175668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans: the estrogen target for vaginal colonization.
    Tarry W; Fisher M; Shen S; Mawhinney M
    J Surg Res; 2005 Dec; 129(2):278-82. PubMed ID: 16111702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy.
    Ickenstein LM; Edwards K; Sjöberg S; Carlsson J; Gedda L
    Nucl Med Biol; 2006 Aug; 33(6):773-83. PubMed ID: 16934696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design.
    Narra VR; Howell RW; Harapanhalli RS; Sastry KS; Rao DV
    J Nucl Med; 1992 Dec; 33(12):2196-201. PubMed ID: 1460515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of diethylstilbestrol on programmed oocyte death and induction of polyovular follicles in neonatal mouse ovaries.
    Kim H; Nakajima T; Hayashi S; Chambon P; Watanabe H; Iguchi T; Sato T
    Biol Reprod; 2009 Nov; 81(5):1002-9. PubMed ID: 19553606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromine-80m radiotoxicity and the potential for estrogen receptor-directed therapy with auger electrons.
    DeSombre ER; Harper PV; Hughes A; Mease RC; Gatley SJ; DeJesus OT; Schwartz JL
    Cancer Res; 1988 Oct; 48(20):5805-9. PubMed ID: 3167838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.